Page 450 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

428 PART IV Specific Malignancies in the Small Animal Patient

97. Robinson TM, Dubielzig RR, McAnulty JF: Malignant mesenchy- 120. Kamstock DA, Ehrhart EJ, Getzy DM, et al.: Recommended
moma associated with an unusual vasoinvasive metastasis in a dog, guide-lines for submission, trimming, margin evaluation, and
J Am Anim Hosp Assoc 34:295–299, 1998. reporting of tumor biopsy specimens in veterinary surgical pathol-
VetBooks.ir 98. Murphy S, Blunden AS, Dennis R, et al.: Intermandibular malig- 121. Eward WC, Mito JK, Eward CA, et al.: A novel imaging system
ogy, Vet Pathol 48:19–31, 2011.
nant mesenchymoma in a crossbreed dog, J Small Anim Pract
47:550–553, 2006.
99. Gomez-Laguna J, Barranco I, Rodriguez-Gomez IM, et al.: Malig- permits real-time in vivo tumor bed assessment after resection
of naturally occurring sarcomas in dogs, Clin Orthop Relat Res
nant mesenchymoma of the heart base in a dog with infiltration 471:834–842, 2013.
of the pericardium and metastasis to the lung, J Comp Pathol 122. Holt D, Parthasarathy AB, Okusanya O, et al.: Intraoperative near-
147:195–198, 2012. infrared fluorescence imaging and spectroscopy identifies residual
100. Weishaar KM, Edmonson EF, Thamm DH, et al.: Malignant mes- tumor cells in wounds, J Biomed Opt 20:76002, 2015.
enchymoma with widespread metastasis including bone marrow 123. Fidel J, Kennedy KC, Dernell WS, et al.: Preclinical validation of
involvement in a dog, Vet Clin Pathol 43:447–452, 2014. the utility of BLZ-100 in providing fluorescence contrast for imag-
101. Machida N, Kobayashi M, Tanaka R, et al.: Primary malignant ing spontaneous solid tumors, Cancer Res 75:4283–4291, 2015.
mixed mesenchymal tumour of the heart in a dog, J Comp Pathol 124. DeWitt SB, Eward WC, Eward CA, et al.: A novel imaging system
128:71–74, 2003. distinguishes neoplastic from normal tissue during resection of soft
102. Ghisleni G, Roccabianca P, Ceruti R, et al.: Correlation between tissue sarcomas and mast cell tumors in dogs, Vet Surg 45:715–722,
fine-needle aspiration cytology and histopathology in the evalua- 2016.
tion of cutaneous and subcutaneous masses from dogs and cats, Vet 125. Cabon Q, Sayag D, Texier I, et al.: Evaluation of intraoperative
Clin Pathol 35:24–30, 2006. fluorescence imaging-guided surgery in cancer-bearing dogs: a
103. Hohenhaus AE, Kelsey JL, Haddad J, et al.: Canine cutaneous and prospective proof-of-concept phase II study in 9 cases, Transl Res
subcutaneous soft tissue sarcoma: an evidence-based review of case 170:73–88, 2016.
management, J Am Anim Hosp Assoc 52:77–89, 2016. 126. Ramanathan RC, A’Hern R, Fisher C, et al.: Prognostic index for
104. Perry JA, Culp WT, Dailey DD, et al.: Diagnostic accuracy of pre- extremity soft tissue sarcomas with isolated local recurrence, Ann
treatment biopsy for grading soft tissue sarcomas in dogs, Vet Comp Surg Oncol 8:278–289, 2011.
Oncol 12:106–113, 2014. 127. Stojadinovic A, Leung DHY, Hoos A, et al.: Analysis of the prog-
105. Postorino NC, Berg RJ, Powers BE, et al.: Prognostic variables for nostic significance of microscopic margins in 2,084 localized pri-
canine hemangiopericytoma: 50 cases (1979-1984), J Am Anim mary adult soft tissue sarcomas, Ann Surg 235:424–434, 2002.
Hosp Assoc 24:501–509, 1988. 128. Zagars GK, Ballo MT, Pisters PWT, et al.: Prognostic factors for
106. Affolter VK, Moore PF: Localized and disseminated histiocytic sar- patients with localized soft-tissue sarcoma treated with conservative
coma of dendritic cell origin in dogs, Vet Pathol 39:74–83, 2002. surgery and radiation therapy: an analysis of 1225 patients, Cancer
107. Sugiura H, Takahashi M, Katagiri H, et al.: Additional wide resec- 97:2530–2543, 2003.
tion of malignant soft tissue tumors, Clin Orthop 394:201–210, 129. Zagars GK, Ballo MT, Pisters PWT, et al.: Surgical margins and
2002. reresection in the management of patients with soft tissue sarcoma
108. Loh ZH, Allan GS, Nicoll RG, et al.: Ultrasonographic character- using conservative surgery and radiation therapy, Cancer 97:2544–
istics of soft tissue tumours in dogs, Aust Vet J 87:323–329, 2009. 2553, 2003.
109. Greene FL, Page DL, Fleming ID, et al.: AJCC cancer staging man- 130. Eilber FC, Rosen G, Nelson SD, et al.: High-grade extremity soft
ual, New York, 2002, Springer. tissue sarcomas: factors predictive of local recurrence and its effect
110. Dernell WS, Withrow SJ, Kuntz CA, et al.: Principles of treatment on morbidity and mortality, Ann Surg 237:218–226, 2003.
for soft tissue sarcoma, Clin Tech Small Anim Pract 13:59–64, 1998. 131. Elmslie RE, Glawe P, Dow SW: Metronomic chemotherapy with
111. Avallone G, Boracchi P, Stefanello D, et al.: Canine perivascular cyclophosphamide and piroxicam effectively delays tumor recur-
wall tumors: high prognostic impact of site, depth, and complete- rence in dogs with incompletely resected soft tissue sarcomas, J Vet
ness of margins, Vet Pathol 51:713–721, 2014. Intern Med 22:1373–1379, 2008.
112. Russell DS, Townsend KL, Gorman E, et al.: Characterizing micro- 132. Spugnini EP, Vincenzi B, Citro G, et al.: Adjuvant electroche-
scopical invasion patterns in canine mast cell tumours and soft tis- motherapy for the treatment of incompletely excised spontaneous
sue sarcomas, J Comp Path 157:231–240, 2017. canine sarcomas, Vivo 21:819–822, 2007.
113. Banks T, Straw R, Thomson M, et al.: Soft tissue sarcomas in dogs: 133. McEntee MC, Samii VF, Walsh P, et al.: Postoperative assessment
a study correlating optimal surgical margin with tumour grade, of surgical clip position in 16 dogs with cancer: a pilot study, J Am
Aust Vet Pract 34:158–163, 2004. Anim Hosp Assoc 40:300–308, 2004.
114. Bray JP: Soft tissue sarcoma in the dog – part 1: a current review, J 134. Henry CJ, Stoll MR, Higginbotham ML, et al.: Effect of timing of
Small Anim Pract 57:510–519, 2016. radiation initiation on post-surgical wound healing in dogs, Proc
115. Pratschke KM, Atherton MJ, Sillito JA, et al.: Evaluation of a Vet Cancer Soc 23:52, 2003.
modified proportional margins approach for surgical resection of 135. Forrest LJ, Chun R, Adams WM, et al.: Postoperative radiotherapy
mast cell tumors in dogs: 40 cases (2008-2012), J Am Vet Med Assoc for canine soft tissue sarcoma, J Vet Intern Med 14:578–582, 2000.
243:1436–1441, 2013. 136. McKnight JA, Mauldin GN, McEntee MC, et al.: Radiation treat-
116. Monteiro B, Boston S, Monteith G: Factors influencing complete ment of incompletely resected soft-tissue sarcomas in dogs, J Am
tumor excision of mast cell tumors and soft tissue sarcomas: a ret- Vet Med Assoc 217:205–210, 2000.
rospective study in 100 dogs, Can Vet J 52:1209–1214, 2011. 137. Heller D, Stebbins ME, Reynolds T, et al.: A retrospective study of
117. Stefanello D, Morello E, Roccabianca P, et al.: Marginal excision 87 cases of canine soft tissue sarcoma 1986–2001, Int J Appl Res Vet
of low-grade spindle cell sarcoma of canine extremities: 35 dogs Med 3:81–87, 2005.
(1996-2006), Vet Surg 37:461–465, 2008. 138. Simon D, Ruslander DM, Rassnick KM, et al.: Orthovoltage
118. McSporran KD: Histologic grade predicts recurrence for margin- radiation and weekly low dose of doxorubicin for the treatment
ally excised canine subcutaneous soft tissue sarcomas, Vet Pathol of incompletely excised soft-tissue sarcomas in 39 dogs, Vet Rec
46:928–933, 2009. 160:321–326, 2007.
119. Reimer SB, Séguin B, DeCock HE, et al.: Evaluation of the effect 139. Graves GM, Bjorling DE, Mahaffey E: Canine hemangioperi-
of routine histologic processing on the size of skin samples obtained cytoma: 23 cases (1967-1984), J Am Vet Med Assoc 192:99–102,
from dogs, Am J Vet Res 66:500–505, 2005. 1988.